(VIANEWS) – WEBSTEP (WSTEP.OL), CREDIT AGRICOLE (ACA.PA), UCB (UCB.BR) are the highest payout ratio stocks on this list.
We have collected information concerning stocks with the highest payout ratio up to now. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. WEBSTEP (WSTEP.OL)
106.92% Payout Ratio
Webstep ASA, together with its subsidiaries, provides information technology (IT) consultancy services to public and private businesses in Norway and Sweden. The company offers digitalization, cloud migration and integration, Internet of Things, machine learning, IT security, robotics, and analytics. Its services include consulting, digitalization, .Net, Java, open source, full stack, front and back end, user experience, integration, mobility, cloud apps, machine learning, business intelligence, big data, data warehousing, virtual robotics, Devops, application service management, and data science services; and cloud computing, cloud services, integration, sensor technology, product and service development, Beacons, enterprise user experience, web analysis, design team, Amazon Web, Azure, prediction, AI, mobility predictive modelling, predictive modelling, hackathon, business analysis, and search engine optimization services. The company serves banking, finance and insurance, public administration, agriculture and food production, IT and telecommunication, commerce, and transportation industries. The company was founded in 2000 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, WEBSTEP has a trailing twelve months EPS of kr1.43.
PE Ratio
WEBSTEP has a trailing twelve months price to earnings ratio of 21.54. Meaning, the purchaser of the share is investing kr21.54 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.66%.
More news about WEBSTEP.
2. CREDIT AGRICOLE (ACA.PA)
63.95% Payout Ratio
Crédit Agricole S.A. provides retail, corporate, insurance, and investment banking products and services in France, Italy, rest of Europe, and internationally. It operates through Asset Gathering; Large Customers; Specialised Financial Services; French Retail Banking – LCL; and International Retail Banking segments. The company offers banking products and services, including savings, current, and money market accounts and deposits; finance, payment, and cash flow management services; consumer finance products; and banking and specialized financial services. It also provides wealth management services comprising a range of savings and investment solutions in traditional or real assets; and savings/retirement, death and disability/creditor/group, and property and casualty insurance products. In addition, the company offers financing solutions for property and equipment investment and renewal requirements; trade receivable financing and management solutions for corporates; and financing services for renewable energy and public infrastructure projects, as well as leasing services. Further, it provides investment banking, structured finance, international trade finance, commercial banking, capital market, and syndication services; asset servicing solutions for investment products, as well as various asset classes, such as execution, clearing, forex, security lending and borrowing, custody, depositary bank, fund administration, middle-office outsourcing solutions, and fund distribution support and issuer services; and online banking services. The company serves retail customers, corporates, banks and financial institutions, government agencies, and local authorities. Crédit Agricole S.A. was founded in 1894 and is headquartered in Montrouge, France. Crédit Agricole S.A. operates as a subsidiary of SAS Rue La Boétie.
Earnings Per Share
As for profitability, CREDIT AGRICOLE has a trailing twelve months EPS of €1.66.
PE Ratio
CREDIT AGRICOLE has a trailing twelve months price to earnings ratio of 7.19. Meaning, the purchaser of the share is investing €7.19 for every euro of annual earnings.
Volume
Today’s last reported volume for CREDIT AGRICOLE is 2012920 which is 75.75% below its average volume of 8302850.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 30, 2023, the estimated forward annual dividend rate is 1.05 and the estimated forward annual dividend yield is 8.96%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 30% and a negative 5.3%, respectively.
Yearly Top and Bottom Value
CREDIT AGRICOLE’s stock is valued at €11.94 at 12:10 EST, way under its 52-week low of €8.09.
More news about CREDIT AGRICOLE.
3. UCB (UCB.BR)
60.47% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €2.13.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 40.86. Meaning, the purchaser of the share is investing €40.86 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.81%.
Yearly Top and Bottom Value
UCB’s stock is valued at €87.04 at 12:10 EST, under its 52-week high of €90.52 and way higher than its 52-week low of €66.62.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 1.33 and the estimated forward annual dividend yield is 1.56%.
More news about UCB.
4. GALP ENERGIA-NOM (GALP.LS)
36.24% Payout Ratio
Galp Energia, SGPS, S.A. operates as an integrated energy operator in Portugal and internationally. The company operates through four segments: Upstream, Industrial & Midstream, Commercial, and Renewables and New Business. The Upstream segment engages in the exploration, development, and production of hydrocarbons primarily in Brazil, Mozambique, and Angola. The Industrial & Midstream segment owns refineries in Portugal, as well as is involved in activities related to energy management of oil products, gas, and electricity. This segment also provides storage and transportation infrastructure for oil and gas products, as well as engages in the sale of electricity to the grid in Portugal and Spain. The Commercial segment is involved in the areas of retail to final business-to-business and business to consumer customers of oil, gas, and electricity. The Renewables and New Business segment is involved in the development of solar and wind power generation projects in Portugal and Spain. In addition, it produces biodiesel, biofuel, and green hydrogen; and operates service stations. Further, the company engages in the reinsurance business. The company was formerly known as Galp – Petróleos e Gás de Portugal, SGPS, S.A. and changed its name to Galp Energia, SGPS, S.A. in September 2000. Galp Energia, SGPS, S.A. was incorporated in 1999 and is headquartered in Lisbon, Portugal.
Earnings Per Share
As for profitability, GALP ENERGIA-NOM has a trailing twelve months EPS of €2.46.
PE Ratio
GALP ENERGIA-NOM has a trailing twelve months price to earnings ratio of 4.29. Meaning, the purchaser of the share is investing €4.29 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.99%.
Sales Growth
GALP ENERGIA-NOM’s sales growth is 0.2% for the current quarter and negative 11.3% for the next.
Yearly Top and Bottom Value
GALP ENERGIA-NOM’s stock is valued at €10.56 at 12:10 EST, way below its 52-week high of €13.29 and way above its 52-week low of €9.33.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Sep 16, 2022, the estimated forward annual dividend rate is 0.52 and the estimated forward annual dividend yield is 4.51%.
More news about GALP ENERGIA-NOM.
